A2.21 The increase of circulating CD4 + T-cells with effector phenotype in patients with systemic lupus erythematosus may be reverted after belimumab therapy
Piantoni, S, Scarsi, M, Andreoli, L, Dall’Ara, F, Zanola, A, Tincani, A, Airò, PVolume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-209124.56
Date:
February, 2016
File:
PDF, 99 KB
english, 2016